Attitude of pregnant and lactating women toward COVID-19 vaccination in Jordan: a cross-sectional study

Author:

Abuhammad Sawsan1ORCID

Affiliation:

1. Department of Maternal and Child Health , Jordan University Of Science And Technology , Irbid 22110 , Jordan

Abstract

Abstract Objectives The objective of this study was to survey pregnant and lactating toward COVID-19 vaccination in Jordan and determine the predictors of this attitude Methods This study used a 10 min anonymous, online, cross-sectional survey to collect data. The survey was carried out between September and October 2021. Eligible study participants included all pregnant and lactating women in Jordan. The participants were recruited through social media, midwives, and gynecologists. Survey was used to collect data from the participants. Results The mean attitude of pregnant and lactating women toward COVID vaccination was moderate 71 (SD=100.5). Many factors were predicted the attitude of pregnant and lactating women toward COVID-19 vaccination. The factors were source of data regarding COVID-19 (B=−0.140, p=0.009), level of income (B=−0.141, p=0.009), and social status (B=0.130, p=0.034). These results mean lower income, people who frequently hearing news from news channel or ministry of health and married are showed more positive attitude toward COVID-19 vaccination for children. Conclusions This is a large national study regarding attitude of pregnant and lactating women toward COVID-19 vaccination in Jordan. This study found that more than 50% for the parents were hesitant to allow their children to receive COVID-19 vaccination. There were no differences between pregnant and lactating women toward COVID-19 vaccination.

Publisher

Walter de Gruyter GmbH

Subject

Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health

Reference29 articles.

1. Skjefte, M, Ngirbabul, M, Akeju, O, Escudero, D, Hernandez-Diaz, S, Wyszynski, DF, et al.. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. Eur J Epidemiol 2021;36:197–211. https://doi.org/10.1007/s10654-021-00728.

2. Mortazavi, F, Mehrabadi, M, KiaeeTabar, R. Pregnant women’s well-being and worry during the COVID-19 pandemic: a cross-sectional study. BMC Pregnancy Childbirth 2021;21:1–11. https://doi.org/10.1186/s12884-021-03548-4.

3. Pfizer, B. Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study. 2021. | Pfpfizeruscom [online]. Available from: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against [Accessed 8 Jun 2021].

4. Moderna, I. Moderna announces primary efficacy analysis in phase 3 COVE study for its COVID-19 vaccine candidate and filing today with US FDA for emergency use authorization. Moderna. 2020. Available from: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-primary-efficacy-analysis-phase-3-cove-study [Accessed 8 Jun 2021].

5. Pratama, NR, Wafa, IA, Budi, DS, Putra, M, Wardhana, MP, Wungu, CDK. Covid-19 vaccination in pregnancy: a systematic review. medRxiv 2021;8. https://doi.org/10.1101/2021.07.04.21259985.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3